CODEXIS, INC. CDXS
Nasdaq · XNAS · stock · Industrial Organic Chemicals
Chart by TradingView
3/9
Piotroski F — financial health
-11.56
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $70.4M | -$44.0M | — | -$23.8M | $50.5M |
| 2024 | $59.3M | -$65.3M | — | -$53.7M | $66.9M |
| 2023 | $70.1M | -$76.2M | — | -$57.1M | $86.6M |
| 2022 | $138.6M | -$33.6M | — | $3.0M | $144.8M |
| 2021 | $104.8M | -$21.3M | — | -$28.1M | $164.4M |
| 2020 | $69.1M | -$24.0M | — | -$20.2M | $170.1M |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -11.56 (distress)
- Working capital / assets 0.484
- Retained earnings / assets -4.105
- EBIT / assets -0.282
- Equity / liabilities 0.519
Source: SEC EDGAR filings · CIK 0001200375 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.